Ascend Wellness Holdings (AAWH) Total Debt (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Total Debt came in at $302.1 million in Q1 2026, down 9.29% year-on-year from $333.0 million in Q1 2025, and down 8.43% quarter-over-quarter from $329.9 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Total Debt (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Total Debt history runs 7 years deep, the most recent figure standing at $302.1 million for Q1 2026.
- On a quarterly basis, Total Debt fell 9.29% year-over-year to $302.1 million in Q1 2026; TTM through Mar 2026 was $302.1 million, a 9.29% decrease from a year earlier, with the FY2025 full-year figure at $329.9 million, down 13.35% from the prior year.
- Total Debt fell to $302.1 million in Q1 2026 per AAWH's latest filing, from $329.9 million in the prior quarter.
- Across five years, Total Debt topped out at $380.7 million in Q4 2024 and bottomed at $233.7 million in Q1 2022.
- The 5-year median for Total Debt is $310.4 million (2022), against an average of $317.9 million.
- Across the five-year window, Total Debt jumped 127.73% in 2022 and dropped 13.35% in 2025, its largest moves.
- Year by year, Total Debt stood at $330.6 million in 2022, then slipped by 7.55% to $305.7 million in 2023, then increased by 24.55% to $380.7 million in 2024, then decreased by 13.35% to $329.9 million in 2025, then slipped by 8.43% to $302.1 million in 2026.
- Per Business Quant, the three latest AAWH Total Debt figures stand at $302.1 million (Q1 2026), $329.9 million (Q4 2025), and $369.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 302.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 302.09 Mn |
| Dec 31, 2025 | 329.89 Mn |
| Sep 30, 2025 | 369.05 Mn |
| Jun 30, 2025 | 349.58 Mn |
| Mar 31, 2025 | 333.02 Mn |
| Dec 31, 2024 | 380.72 Mn |
| Sep 30, 2024 | 305.90 Mn |
| Jun 30, 2024 | 309.29 Mn |
| Mar 31, 2024 | 310.52 Mn |
| Dec 31, 2023 | 305.67 Mn |
| Sep 30, 2023 | 307.42 Mn |
| Jun 30, 2023 | 309.80 Mn |
| Mar 31, 2023 | 324.05 Mn |
| Dec 31, 2022 | 330.63 Mn |
| Sep 30, 2022 | 310.44 Mn |
| Jun 30, 2022 | 293.28 Mn |
| Mar 31, 2022 | 233.70 Mn |
| Dec 31, 2021 | 258.79 Mn |
| Sep 30, 2021 | 255.57 Mn |
| Jun 30, 2021 | 128.79 Mn |